Seminar's New Group Leader, Jeff Goldblum, Joins Broadway Comedy April 3 | Playbill

Related Articles
News Seminar's New Group Leader, Jeff Goldblum, Joins Broadway Comedy April 3 Broadway's Seminar, the new play by Theresa Rebeck, gets a new poison pen in the form of Jeff Goldblum starting on April 3. The veteran of Broadway's The Pillowman and Hollywood's "The Fly," succeeds Alan Rickman as a literary lion who judges the work of young novelists. Zoe Lister-Jones (The Little Dog Laughed) and Justin Long (TV's "Ed") also join the troupe on Tuesday.

//assets.playbill.com/editorial/891de34a35a14f35c8221f341afe597c-goldb200.jpg
Jeff Goldblum Photo by Joseph Marzullo/WENN

Rickman, Lily Rabe and Hamish Linklater exited the play following the April 1 matinee at the Golden Theatre. Lister-Jones succeeds Rabe as Kate, who organizes the group, and Long succeeds Linklater as unsure writer Martin.

Hettienne Park and Jerry O'Connell ("Stand By Me," "The Defenders") continue in roles they created — Izzy and Douglas, respectively. Sam Gold (The Big Meal, Look Back in Anger) directs.

The new quintet is set to play eight weeks, from April 3 through May 27.

Pulitzer Prize finalist and Peabody Award winner Theresa Rebeck also wrote the plays Mauritius, The Scene, The Understudy and Omnium Gatherum (among many others), was an "NYPD Blue" writer and created the NBC series "Smash." Read more about Seminar in the Playbill Vault

Seminar opened Nov. 20, 2011, and is produced by Jeffrey Finn, Jill Furman, John N. Hart Jr., Patrick Milling Smith, Roy Furman, David Ian, David Mirvish, Amy Nauiokas and James Spry.

Tickets are $51.50-126.50, with Premium seating also available. Tickets can be purchased by visiting www.telecharge.com, calling (212) 239-6200 or going in person to The Golden Theatre box office (252 West 45th Street).

Visit www.SeminarOnBroadway.com.

 
RELATED:
Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!